Frailty in Older Patients With Atrial Fibrillation and Its Relationship With Anticoagulant Use: A Multi‐Centred Observational Study in New South Wales
Australasian Journal on Ageing · 2025
DOI: 10.1111/ajag.70101 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Australasian Journal on Ageing, 2025. Verfasst von Tu N Nguyen und 2 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Frailty, Frail Elderly. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Sydney Health Partners Geriatric Medicine Clinical Academic Group.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objectives
This study aimed to examine the prevalence of frailty in hospitalised older patients with atrial fibrillation (AF) and its relationship with oral anticoagulant (OAC) prescription during admission. The secondary aim was to examine the association between frailty and rate‐/rhythm‐control medication prescriptions.
Methods
This retrospective observational study included adults aged 65 years or older with AF admitted to six hospitals in Australia in 2022. Frailty was defined by a Frailty Index ≥ 0.25. Logistic regression models were applied to examine the association between frailty and the prescriptions of OAC, rate‐control and rhythm‐control drugs during hospitalisation. Results are presented as odds ratios (OR) and 95% confidence intervals (CI).
Results
There were 685 patients, with a mean age of 82.6 (SD 8.3), 50% female and 43% identified as frail. Overall, 76% were prescribed OAC (68% in the frail versus 81% in the non‐frail, p < 0.001), 38% received rate‐control drugs (42% in the frail vs. 34% in the non‐frail, p = 0.04), 27% received rhythm‐control drugs (23% in the frail vs. 31% in the non‐frail, p = 0.02). The adjusted ORs of frailty on prescriptions were 0.58 (95% CI 0.39–0.86) for OAC, 1.75 (95% CI 1.22–2.52) for rate‐control drugs and 0.83 (95% CI 0.55–1.24) for rhythm‐control drugs.
Conclusions
The study revealed a high prevalence of frailty in older inpatients with AF. Frailty was associated with reduced likelihood of prescription of OAC and increased likelihood of prescribing rate‐control medications, with no independent impact on rhythm‐control therapy. Further studies are needed to understand these prescribing patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The George Institute for Global Health, Sydney, New South Wales, Australia.
- Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
- Department of Clinical Pharmacology and Aged Care, Faculty of Medicine and Health, Kolling Institute, The University of Sydney and Northern Sydney Local Health District, Royal North Shore Hospital, Sydney, New South Wal…
ORCID-Profile: Kenji Fujita
Förderung
- Sydney Health Partners Geriatric Medicine Clinical Academic Group
Zitieren
APA
Nguyen, T. N., Fujita, K., & Hilmer, S. N. (2025). Frailty in Older Patients With Atrial Fibrillation and Its Relationship With Anticoagulant Use: A Multi‐Centred Observational Study in New South Wales. Australasian Journal on Ageing. https://doi.org/10.1111/ajag.70101
Vancouver
Nguyen TN, Fujita K, Hilmer SN. Frailty in Older Patients With Atrial Fibrillation and Its Relationship With Anticoagulant Use: A Multi‐Centred Observational Study in New South Wales. Australasian Journal on Ageing. 2025. doi:10.1111/ajag.70101
BibTeX
@article{Nguyen2025,
author = {Nguyen, Tu N and Fujita, Kenji and Hilmer, Sarah N},
title = {Frailty in Older Patients With Atrial Fibrillation and Its Relationship With Anticoagulant Use: A Multi‐Centred Observational Study in New South Wales},
journal = {Australasian Journal on Ageing},
year = {2025},
doi = {10.1111/ajag.70101}
}
EUVIMED